These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20074084)

  • 1. "Absolute" or "added" predictive value?
    Koole O; Van den Ende J
    Trop Med Int Health; 2010 Mar; 15(3):382; author reply 382-4. PubMed ID: 20074084
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment: predictors of response--updating the traditional list.
    Gallant JE
    AIDS Read; 2006 Aug; 16(8):432-3. PubMed ID: 16933377
    [No Abstract]   [Full Text] [Related]  

  • 4. Inexpensive CD4 counting for the developing world.
    Secko D
    CMAJ; 2005 Aug; 173(5):478. PubMed ID: 16129864
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
    Phillips AN; Gilks C; Lundgren JD
    Arch Intern Med; 2009 May; 169(9):904; author reply 904-5. PubMed ID: 19433706
    [No Abstract]   [Full Text] [Related]  

  • 6. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
    Mildvan D; Bosch RJ; Kim RS; Spritzler J; Haas DW; Kuritzkes D; Kagan J; Nokta M; DeGruttola V; Moreno M; Landay A
    J Infect Dis; 2004 May; 189(10):1811-20. PubMed ID: 15122517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
    Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
    Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand.
    Chaiwarith R; Wachirakaphan C; Kotarathititum W; Praparatanaphan J; Sirisanthana T; Supparatpinyo K
    Int J Infect Dis; 2007 Sep; 11(5):413-6. PubMed ID: 17331776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
    Masquelier B; Capdepont S; Neau D; Peuchant O; Taupin JL; Coakley E; Lie Y; Carpentier W; Dabis F; Fleury HJ;
    AIDS; 2007 Jan; 21(1):103-6. PubMed ID: 17148975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to highly active antiretroviral therapy.
    Low A; Markowitz M
    AIDS Read; 2006 Aug; 16(8):425-8, 430-1, 434, 436. PubMed ID: 16933376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Call for action to secure universal access to ART in developing countries.
    Orsi F; Carrieri MP; Coriat B; Delaporte E; Moatti JP; Spire B; Taverne B; Barré-Sinoussi F
    Lancet; 2010 May; 375(9727):1693-4. PubMed ID: 20472168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes for low positive predictive values of CD4 counts for antiretroviral treatment failure.
    Eisenhut M
    Int J Infect Dis; 2008 Sep; 12(5):565; author reply 566. PubMed ID: 18403226
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
    Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
    Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who will bridge the HIV treatment-prevention gap?
    Weis P; Schmid G; De Cock K
    J Infect Dis; 2008 Jul; 198(2):293-4. PubMed ID: 18593296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.